The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine

Neurochemical Research

Volumn 35, Issue 9, 2010, Pages 1368-1375

  Liu, Hanqing ^a   Sun, Yan ^a   Gao, Yan ^a   Chen, Fangfang ^a   Xu, Mingbo ^b   Liu, Zhifeng ^a  

^a YANTAI UNIVERSITY   (China)

^b Beijing SL Pharmaceutical Co Ltd   (China)

Author keywords

Dorsal root ganglion; Intracellular calcium Whole cell patch clamp; Synergistic analgesic effect; Transient receptor potential vanilloid 1

Indexed keywords

CALCIUM; CAPSAICIN; DICLOFENAC; FERULIC ACID; OXYMATRINE; VANILLOID RECEPTOR 1;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; EVOKED RESPONSE; MALE; MOUSE; NERVE POTENTIAL; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPINAL CORD NERVE CELL; SPINAL GANGLION;

ACETIC ACID; ALKALOIDS; ANALGESICS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COUMARIC ACIDS; FORMALDEHYDE; GANGLIA, SPINAL; MALE; MICE; NEURONS; PAIN; PAIN MEASUREMENT; PATCH-CLAMP TECHNIQUES; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; TRPV CATION CHANNELS;

ANIMALIA;

EID: 77957844279     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0193-4     Document Type: Article

References (26)

1. Ogiwara T, Satoh K, Kadoma Y et al (2002) Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 22:2711-2717 (Pubitemid 36069302)
2. Wang BH, Ou-Yang JP (2005) Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev 23:161-172
3. Masuda T, Yamada K, Maekawa T et al (2006) Antioxidant mechanism studies on ferulic acid: identification of oxidative coupling products from methyl ferulate and linoleate. J Agric Food Chem 54:6069-6074 (Pubitemid 44342244)
4. Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40:92-100 (Pubitemid 46623810)
5. Chen XS, Wang GJ, Cai X et al (2001) Inhibition of hepatitis B virus by Oxymatrine in vivo. World J Gastroenterol 7:49-52 (Pubitemid 32170898)
6. Honore P, Wismer CT, Mikusa J et al (2005) A-425619 [1-iso-quinolin-5-yl- 3-(4-trifluoromethyl-benzyl)-urea], A novel transient receptor potential type V1 receptor antagonist, relieves path physiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 314:410-421 (Pubitemid 41058279)
7. Ramsey IS, Delling M, Clapham DE (2006) An introduction to TRP channels. Annu Rev Physiol 68:619-647
8. Benham CD, Davis JB, Randall AD (2002) Vanilloid and TRP channels: A family of lipid-gated cation channels. Neurophar-macology 42:873-888 (Pubitemid 34628619)
9. Mezey E, Toth ZE, Cortright DN et al (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 97:3655-3660 (Pubitemid 30183358)
10. Sanchez JF, Krause JE, Cortright DN (2001) The distribution and regulation of vanilloid receptor VR1 and VR1 5' splice variant RNA expression in rat. Neuroscience 107:373-381
11. Caterina MJ, Julius D (2001) The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci 24:487-517 (Pubitemid 32695237)
12. Veronesi B, Oortgiesen M (2006) The TRPV1 receptor: target of toxicants and therapeutics. Toxicol Sci 89:1-3 (Pubitemid 43013750)
13. Bruce BR, Rachid EL et al (2007) [3H] A-778317 [1-((R)-5-tert-Butyl- indan-1-yl)-3-isoquinolin-5-yl-urea]: A novel, stereoselec-tive, high-affinity antagonist is A useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor. J Pharmacol Exp Ther 323:285-293
14. Wang ST, Chen S, Guo M et al (2008) Inhibitory effect of co-chinchinenin B on capsaicin-activated responses in rat dorsal root ganglion neurons. Brain Res 1201:34-40
15. Soukupová M, Doležal T, Kršiak M (2009) The synergistic interaction between rilmenidine and paracetamol in the writhing test in mice. Naunyn Schmiedebergs Arch Pharmacol 379:575-580
16. Sun XC, Chen WN, Li SQ et al (2008) Fluorocitrate, an inhibitor of glial metabolism, inhibits the up-regulation of NOS expression, activity and NO production in the spinal cord induced by formalin test in rats. Neurochem Res 34:351-359
17. Hunskaar S, Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103-104 (Pubitemid 17094194)
18. Santiago AR, Carvalho CM (2008) Differential contribution of L-, N-, and P/Q-type calcium channels to [Ca2+] changes evoked by kainite in hippocampal neurons. Neurochem Res 33:1501-1508
19. Ohta T, Imagawa T, Ito S (2009) Involvement of transient receptor potential vanilloid subtype 1 (TRPV1) in analgesic action of methylsalicylate. Mol Pharmacol 75:307-317
20. Luszczki JJ, Czuczwar SJ et al (2004) Isobolographic profile of interactions between tiagabine and gabapentin: A preclinical study. Naunyn Schmiedebergs Arch Pharmacol 369:434-446
21. Ferrer-Montiel A, Garcia-Martinez C, Morenilla-Palao C et al (2004) Molecular architecture of the vanilloid receptor. Insights for drug design. Eur J Biochem 271:1820-1826 (Pubitemid 38657336)
22. Brauchi S, Orta G, Salazar M et al (2006) A hot-sensing cold receptor: C-terminal domain determines thermosensation in transient receptor potential channels. J Neurosci 26:4835-1840 (Pubitemid 44315324)
23. Wang Y (2008) The functional regulation of TRPV1 and its role in pain sensitization. Neurochem Res 33:2008-2012
24. Shin J, Cho H, Hwang SW et al (2002) Bradykinin-12-lipox-ygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99:10150-10155 (Pubitemid 34831187)
25. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N et al (2004) Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 279:25665-25672 (Pubitemid 38756829)
26. Nurse P (1990) Universal control mechanism regulation onset of M-phase. Nature 344:503-508 (Pubitemid 20124423)